...
机译:多巴胺激动剂和单胺氧化酶B抑制剂的长期有效性与百佳肽作为帕金森病的初始治疗(PD MED):大,开放标签,务实的随机试验
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
University of OxfordOxford United Kingdom;
University of OxfordOxford United Kingdom;
University of GlasgowGlasgow United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
City HospitalsSunderland United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Addenbrooke's HospitalCambridge United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
University of OxfordOxford United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
Birmingham Clinical Trials Unit University of Birmingham United Kingdom;
University of GlasgowGlasgow United Kingdom;
Addenbrooke's HospitalCambridge United Kingdom;
Addenbrooke's HospitalCambridge United Kingdom;
Addenbrooke's HospitalCambridge United Kingdom;
Addenbrooke's HospitalCambridge United Kingdom;
Addenbrooke's HospitalCambridge United Kingdom;
Addenbrooke's HospitalCambridge United Kingdom;
Addenbrooke's HospitalCambridge United Kingdom;
Addenbrooke's HospitalCambridge United Kingdom;
Addenbrooke's HospitalCambridge United Kingdom;
Addenbrooke's HospitalCambridge United Kingdom;
Arrowe Park HospitalWirral United Kingdom;
Bucknall HospitalStoke on Trent United Kingdom;
Bucknall HospitalStoke on Trent United Kingdom;
Arrowe Park HospitalWirral United Kingdom;
Bucknall HospitalStoke on Trent United Kingdom;
Bedford HospitalBedford United Kingdom;
Bedford HospitalBedford United Kingdom;
Bedford HospitalBedford United Kingdom;
Bedford HospitalBedford United Kingdom;
Bedford HospitalBedford United Kingdom;
Birmingham Heartlands HospitalBirmingham United Kingdom;
Birmingham Heartlands HospitalBirmingham United Kingdom;
Birmingham Heartlands HospitalBirmingham United Kingdom;
Bishop Auckland General Hospital United Kingdom;
Bishop Auckland General Hospital United Kingdom;
Delancey HospitalCheltenham United Kingdom;
Delancey HospitalCheltenham United Kingdom;
Delancey HospitalCheltenham United Kingdom;
Delancey HospitalCheltenham United Kingdom;
Bridlington and District HospitalBridlington United Kingdom;
Bridlington and District HospitalBridlington United Kingdom;
Bridlington and District HospitalBridlington United Kingdom;
Brighton General HospitalBrighton United Kingdom;
Brighton General HospitalBrighton United Kingdom;
Bronglais General Hospital United Kingdom;
Bronllys HospitalBrecon United Kingdom;
Bronllys HospitalBrecon United Kingdom;
Brookfields HospitalCambridge United Kingdom;
Brookfields HospitalCambridge United Kingdom;
Brookfields HospitalCambridge United Kingdom;
Brookfields HospitalCambridge United Kingdom;
Calderdale Royal HospitalHalifax United Kingdom;
Calderdale Royal HospitalHalifax United Kingdom;
Calderdale Royal HospitalHalifax United Kingdom;
Calderdale Royal HospitalHalifax United Kingdom;
Calderdale Royal HospitalHalifax United Kingdom;
City HospitalBirmingham United Kingdom;
City HospitalBirmingham United Kingdom;
City HospitalBirmingham United Kingdom;
City HospitalBirmingham United Kingdom;
City HospitalsSunderland United Kingdom;
City HospitalsSunderland United Kingdom;
City HospitalsSunderland United Kingdom;
City HospitalsSunderland United Kingdom;
City HospitalsSunderland United Kingdom;
City HospitalsSunderland United Kingdom;
City HospitalsSunderland United Kingdom;
City HospitalsSunderland United Kingdom;
City HospitalsSunderland United Kingdom;
Colchester General HospitalColchester United Kingdom;
Colchester General HospitalColchester United Kingdom;
Colchester General HospitalColchester United Kingdom;
Colchester General HospitalColchester United Kingdom;
Colchester General HospitalColchester United Kingdom;
Darlington Memorial HospitalDarlington United Kingdom;
Darlington Memorial HospitalDarlington United Kingdom;
Darlington Memorial HospitalDarlington United Kingdom;
Darlington Memorial HospitalDarlington United Kingdom;
Delancey HospitalCheltenham United Kingdom;
Dumfries and Galloway Royal InfirmaryDumfries United Kingdom;
Dumfries and Galloway Royal InfirmaryDumfries United Kingdom;
Dumfries and Galloway Royal InfirmaryDumfries United Kingdom;
Dumfries and Galloway Royal InfirmaryDumfries United Kingdom;
Dumfries and Galloway Royal InfirmaryDumfries United Kingdom;
Dumfries and Galloway Royal InfirmaryDumfries United Kingdom;
Dumfries and Galloway Royal InfirmaryDumfries United Kingdom;
Eryri HospitalCaernarfon United Kingdom;
Eryri HospitalCaernarfon United Kingdom;
Eryri HospitalCaernarfon United Kingdom;
Eryri HospitalCaernarfon United Kingdom;
机译:多巴胺激动剂和单胺氧化酶B抑制剂的长期有效性与百佳肽作为帕金森病的初始治疗(PD MED):大,开放标签,务实的随机试验
机译:帕金森氏病和运动障碍患者的缓释卡比多巴-左旋多巴(IPX066)与速释卡比多巴-左旋多巴的比较:一项3期随机,双盲试验。
机译:优化帕金森病的长期治疗方法:左旋多巴,多巴胺激动剂和治疗相关的运动障碍。
机译:神经途径和受体机制介导刺激诱发的纹状体多巴胺释放:与深部脑刺激有关作为帕金森氏病的治疗方法
机译:在轻度至中度帕金森氏病中物理疗法和职业疗法与无疗法的临床有效性和成本效益:一项大型实用随机对照试验(PD REHAB)。
机译:PND41帕金森氏病问卷(PDQ-39)作为深部脑刺激与最佳药物疗法与仅针对晚期帕金森氏病的最佳药物疗法(PD SURG TRIAL)进行比较的试验的主要终点:一项随机,开放标签的试验